Sign in

Private company

Radius Health, Inc.

American pharmaceutical preparations company based in Boston, active since 20082

In its 2022 annual report the company says: “We are a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, neuroscience, and oncology. We are also developing RAD011, a pharmaceutical-grade synthetic cannabidiol oral solution, manufactured utilizing traditional pharmaceutical manufacturing processes.”83

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations2
  • HeadquartersBoston, United States2
  • Incorporated inDE3
  • Business addressAttn: Principal Finance Officer, 22 Boston Wharf Road, 7Th Floor, Boston, Ma 022103
  • Filer categoryLarge accelerated filer3
  • Legal formCorporation2
  • LEI549300EV6I2M6E0YVT272
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O Corporation Service Company, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 44995952

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

-23.6%Operating margin4
-30.5%Net margin4
-3.6%Revenue growth, 20214
-$22.5MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Research and development48¢$134.6M
  • Selling, general and admin46¢$130.5M
  • Interest6¢$18.3M

Out of $230.0M in revenue.4 The company lost money this year.

Financial statements

Revenue564$230.0M in 2021
0$100.0M$200.0M$300.0M2015: $0$020152016: $0$020162017: $12.1M$12.1M20172018: $99.2M$99.2M2018+719%2019: $173.3M$173.3M2019+75%2020: $238.6M$238.6M2020+38%2021: $230.0M$230.0M2021−4%
Operating income57864-$54.3M in 2021−45% since 2015
-$300.0M-$200.0M-$100.0M02015: -$99.1M-$99.1M20152016: -$184.9M-$184.9M2016+87%2017: -$249.0M-$249.0M2017+35%2018: -$204.1M-$204.1M2018−18%2019: -$112.2M-$112.2M2019−45%2020: -$82.4M-$82.4M2020−27%2021: -$54.3M-$54.3M2021−34%
Net income57864-$70.2M in 2021−31% since 2015
-$300.0M-$200.0M-$100.0M02015: -$101.5M-$101.5M20152016: -$182.8M-$182.8M2016+80%2017: -$254.2M-$254.2M2017+39%2018: -$221.3M-$221.3M2018−13%2019: -$133.0M-$133.0M2019−40%2020: -$109.2M-$109.2M2020−18%2021: -$70.2M-$70.2M2021−36%
Fiscal year2015201620172018201920202021
Revenue$05$05$12.1M5$99.2M6$173.3M4$238.6M4$230.0M4
Cost of revenue$07$932.0K7$7.6M7
Research and development$68.3M5$107.4M7$83.1M8$99.9M6$116.8M4$159.7M4$134.6M4
Selling, general and admin$152.7M4$144.2M4$130.5M4
Operating income-$99.1M5-$184.9M7-$249.0M8-$204.1M6-$112.2M4-$82.4M4-$54.3M4
Interest$1.9M5$07$8.3M8$23.0M6$24.9M4$28.0M4$18.3M4
Income tax$05$07$08$06$04$04$04
Net income-$101.5M5-$182.8M7-$254.2M8-$221.3M6-$133.0M4-$109.2M4-$70.2M4
Earnings per share-$2.894-$2.354-$1.494
Earnings per share (diluted)-$2.894-$2.354-$1.494
Shares (weighted, basic)47.2M shares4
Shares (weighted, diluted)47.2M shares4

Compare Radius Health, Inc. with another company

Corporate structure

Radius Health, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Radius Health, Inc.

  • Radius Health, Inc. Boston, Massachusetts, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Radius Health, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$4.8M4 Dec 31, 2021$4.8M4 Dec 31, 2020+0.6%
Accumulated depreciation$4.2M4 Dec 31, 2021$4.0M4 Dec 31, 2020+4.4%
Property and equipment, net$647.0K4 Dec 31, 2021$796.0K4 Dec 31, 2020−18.7%
Operating-lease assets (leased space)$835.0K4 Dec 31, 2021$3.9M4 Dec 31, 2020−78.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$111.5M4 Dec 31, 2021$91.4M4 Dec 31, 2020+22.0%
Marketable securities, current$04 Dec 31, 2021$23.3M4 Dec 31, 2020−100.0%
Debt securities available for sale$23.3M4 Dec 31, 2020

Intangibles and goodwill

ItemLatestA year beforeChange
Finite-lived intangibles, gross$8.7M4 Dec 31, 2021$8.7M4 Dec 31, 20200%
Accumulated amortization$3.7M4 Dec 31, 2021$2.9M4 Dec 31, 2020+27.3%
Finite-lived intangibles, net$5.0M4 Dec 31, 2021$5.8M4 Dec 31, 2020−13.8%

Inventory

ItemLatestA year beforeChange
Inventory, total$11.4M4 Dec 31, 2021$9.2M4 Dec 31, 2020+24.0%
Raw materials$7.2M4 Dec 31, 2021$5.2M4 Dec 31, 2020+36.9%
Work in process$1.3M4 Dec 31, 2021$667.0K4 Dec 31, 2020+100.1%
Finished goods$2.9M4 Dec 31, 2021$3.3M4 Dec 31, 2020−12.2%

Leadership

Who has led Radius Health, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Cecil Richard Lyttle2011
  2. Michael S. Wyzga2012
  3. Drew J. Fromkin2013
  4. Jesper Hoiland2017–2020
  5. G. Kelly Martin2020–2022

President

  1. Peter Steven St2008
  2. Cecil Richard Lyttle2011–2013
  3. Drew J. Fromkin2013
  4. Jesper Hoiland2017–2020
  5. G. Kelly Martin2020–2022

Chief financial officer

  1. Brian Nicholas Harvey2011–2017
  2. Jose Carmona2017–2020
  3. Mark William Conley2022
2010201520202025
Board members and other officers (44)

Former names

  • MPM ACQUISITION CORPApr 16, 2008 to May 13, 20113

Timeline

  1. Aug 15, 20228-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale59
  2. Aug 2, 20228-K Entered a material agreement60
  3. Jul 28, 20228-K Shareholder vote61
  4. Jun 27, 20228-K Other events62
  5. Jun 23, 20228-K Entered a material agreement63
  6. Jun 22, 20228-K Regulation FD disclosure64
  7. Jun 8, 20228-K Ended a material agreement; Other events65
  8. Jun 6, 20228-K Regulation FD disclosure66
  9. May 23, 20228-K Executive or director change; Bylaws or fiscal year changed; Regulation FD disclosure67
  10. May 5, 20228-K Results of operations68
  11. Apr 5, 20228-K Regulation FD disclosure69
  12. Mar 16, 20228-K Executive or director change; Regulation FD disclosure70
  13. Apr 29, 2020New chief executive G. Kelly Martin becomes CEO12
  14. Jul 18, 2017New chief executive Jesper Hoiland becomes CEO13
  15. Nov 18, 2013New chief executive Drew J. Fromkin becomes CEO14
  16. Apr 20, 2012New chief executive Michael S. Wyzga becomes CEO15
  17. Apr 29, 2011New chief executive Cecil Richard Lyttle becomes CEO16
  18. Feb 4, 2008Founded Radius Health, Inc. is founded2

Calendar

When it reported results

  1. May 5, 2022Reported quarterly or annual results68
  2. Feb 24, 2022Reported quarterly or annual results71
  3. Nov 8, 2021Reported quarterly or annual results72

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

127 filings to the SEC since October 2021: 2 annual reports, 3 quarterly reports, 16 major events, 43 insider forms, 19 large holders, 44 other. The latest 20:

  1. Aug 30, 2022SC 13D/A EDGAR
  2. Aug 30, 20224 FORM 4 SUBMISSION EDGAR
  3. Aug 26, 2022SC 13D/A AMENDMENT NO. 5 TO THE SCHEDULE 13D EDGAR
  4. Aug 25, 202215-12G EDGAR
  5. Aug 17, 2022SC 13G EDGAR
  6. Aug 15, 20228-K EDGAR
  7. Aug 15, 2022S-8 POS EDGAR
  8. Aug 15, 2022S-8 POS EDGAR
  9. Aug 15, 2022S-8 POS EDGAR
  10. Aug 15, 2022S-8 POS EDGAR
  11. Aug 15, 2022S-8 POS EDGAR
  12. Aug 15, 2022S-8 POS EDGAR
  13. Aug 15, 2022S-8 POS EDGAR
  14. Aug 15, 2022S-8 POS EDGAR
  15. Aug 15, 2022S-8 POS EDGAR
  16. Aug 15, 20224 FORM 4 SUBMISSION EDGAR
  17. Aug 15, 20224 FORM 4 SUBMISSION EDGAR
  18. Aug 15, 20224 FORM 4 SUBMISSION EDGAR
  19. Aug 15, 20224 FORM 4 SUBMISSION EDGAR
  20. Aug 15, 20224 FORM 4 SUBMISSION EDGAR

The 127 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

12 open-market trades by officers, directors and large owners since October 2021: 12 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 11, 2022Rubric Capital Management LP10% ownerBuy1,678,954$10.07$16.9MForm 4
Aug 10, 2022Rubric Capital Management LP10% ownerBuy4,012$10.07$40.4KForm 4
May 18, 2022BB BIOTECH AG10% ownerBuy477,824$5.57$2.7MForm 4
Jan 6, 2022BIOTECH TARGET N V10% ownerBuy300,000$6.31$1.9MForm 4
Jan 5, 2022BIOTECH TARGET N V10% ownerBuy250,000$6.30$1.6MForm 4
Dec 16, 2021Rubric Capital Management LP10% ownerBuy146,685$7.07$1.0MForm 4
Dec 15, 2021Rosen David Efraim10% ownerBuy180,744$6.77$1.2MForm 4
Dec 14, 2021Rosen David Efraim10% ownerBuy94,103$6.81$640.8KForm 4
Dec 13, 2021Rosen David Efraim10% ownerBuy187,391$7.08$1.3MForm 4
Dec 10, 2021Rosen David Efraim10% ownerBuy768,171$7.18$5.5MForm 4
Dec 9, 2021Rosen David Efraim10% ownerBuy264,644$7.58$2.0MForm 4
Dec 8, 2021Rosen David Efraim10% ownerBuy560,691$8.02$4.5MForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Radius Health, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARRadius Health, Inc.1
  • CIK0001428522
  • Employer ID (EIN)80-01457321
  • Filer statusLarge accelerated filer1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • Business addressAttn: Principal Finance Officer, 22 Boston Wharf Road, 7Th Floor, Boston, MA 022101
  • Phone617-551-40001
  • Shares outstanding47,620,498 as of Aug 4, 202210
  • Public float$900.0M as of Jun 30, 202182
  • On EDGAR sinceApr 16, 20081
  • Filings995 in all: 4 (354), 8-K (158), 3 (67), SC 13G/A (48), SC 13D/A (47), 10-Q (44), CT ORDER (24), CORRESP (21)1
    All 58 form types

    UPLOAD (21), SC 13G (19), SC 13D (18), 10-K (14), S-1/A (14), DEFA14A (12), 8-K/A (10), 5 (9), S-8 (9), S-8 POS (9), 424B5 (7), DEF 14A (7), DFAN14A (6), 4/A (5), SC TO-T/A (5), SC14D9C (5), 10-Q/A (4), 424B3 (4), DEF 14C (4), EFFECT (4), PRE 14C (4), S-1 (3), SC 14D9/A (3), 10-K/A (2), 8-A12B (2), D (2), DEFC14A (2), POS AM (2), PREC14A (2), RW (2), SC 14F1 (2), SEC STAFF LETTER (2), 10-12G (1), 15-12G (1), 25-NSE (1), 3/A (1), 305B2 (1), 424B2 (1), 424B4 (1), ARS (1), CERTNAS (1), DEFR14C (1), FWP (1), POSASR (1), PRER14C (1), PRRN14A (1), S-3 (1), S-3ASR (1), SC 14D9 (1), SC TO-T (1)

  • Latest filingsAnnual report (10-K) Feb 24, 2022
    Quarterly report (10-Q) Aug 9, 2022
    Proxy statement (DEF 14A) Apr 22, 2021
    Latest 8-K (8-K) Aug 15, 2022

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
    SEC EDGAROther events
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83